FOXD3 controls pluripotency through modulating enhancer activity
- PMID: 27488581
- PMCID: PMC4958055
- DOI: 10.21037/sci.2016.05.03
FOXD3 controls pluripotency through modulating enhancer activity
Conflict of interest statement
Comment on
-
FOXD3 Regulates Pluripotent Stem Cell Potential by Simultaneously Initiating and Repressing Enhancer Activity.Cell Stem Cell. 2016 Jan 7;18(1):104-17. doi: 10.1016/j.stem.2015.10.003. Cell Stem Cell. 2016. PMID: 26748757 Free PMC article.
Similar articles
-
Tuning FOXD3 expression dose-dependently balances human embryonic stem cells between pluripotency and meso-endoderm fates.Biochim Biophys Acta Mol Cell Res. 2019 Dec;1866(12):118531. doi: 10.1016/j.bbamcr.2019.118531. Epub 2019 Aug 12. Biochim Biophys Acta Mol Cell Res. 2019. PMID: 31415841
-
Foxd3 Promotes Exit from Naive Pluripotency through Enhancer Decommissioning and Inhibits Germline Specification.Cell Stem Cell. 2016 Jan 7;18(1):118-33. doi: 10.1016/j.stem.2015.09.010. Cell Stem Cell. 2016. PMID: 26748758 Free PMC article.
-
Modulation of FOXD3 activity in human embryonic stem cells directs pluripotency and paraxial mesoderm fates.Stem Cells. 2012 Oct;30(10):2188-98. doi: 10.1002/stem.1200. Stem Cells. 2012. PMID: 22887036
-
Tuning Forkhead Box D3 overexpression to promote specific osteogenic differentiation of human embryonic stem cells while reducing pluripotency in a three-dimensional culture system.J Tissue Eng Regen Med. 2018 Dec;12(12):2256-2265. doi: 10.1002/term.2757. Epub 2018 Nov 12. J Tissue Eng Regen Med. 2018. PMID: 30350469
-
The paradox of Foxd3: how does it function in pluripotency and differentiation of embryonic stem cells?Stem Cell Investig. 2016 Nov 4;3:73. doi: 10.21037/sci.2016.09.20. eCollection 2016. Stem Cell Investig. 2016. PMID: 27868055 Free PMC article.
Cited by
-
From Pioneer to Repressor: Bimodal foxd3 Activity Dynamically Remodels Neural Crest Regulatory Landscape In Vivo.Dev Cell. 2018 Dec 3;47(5):608-628.e6. doi: 10.1016/j.devcel.2018.11.009. Dev Cell. 2018. PMID: 30513303 Free PMC article.
-
Activation of Tyrosine Metabolism in CD13+ Cancer Stem Cells Drives Relapse in Hepatocellular Carcinoma.Cancer Res Treat. 2020 Apr;52(2):604-621. doi: 10.4143/crt.2019.444. Epub 2019 Dec 27. Cancer Res Treat. 2020. PMID: 32019286 Free PMC article.
References
Publication types
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources